Skip to main content
. 2004 Jan 26;2004(1):CD003133. doi: 10.1002/14651858.CD003133.pub2

2.3. Analysis.

Comparison 2 Leukotriene Receptor Antagonists (LTRA) + ICS vs. DOUBLE dose of ICS in SYMPTOMATIC PATIENTS, Outcome 3 Patients with 1 or more exacerbations requiring hospital admission at LICENSED DOSES.